BACKGROUND Coronary computed tomography angiography (CTA)-verified positive remodeling and low attenuation plaques are considered morphological characteristics of high-risk plaque (HRP) and predict short-term risk of acute coronary syndrome (ACS).
C oronary computed tomography angiography (CTA) allows noninvasive assessment of luminal stenosis, as well as plaque morphology (1) (2) (3) (4) . Several reports have confirmed CTA's diagnostic accuracy for identifying significantly obstructive disease, and the severity of such stenosis was also predictive of major adverse cardiac events (5) (6) (7) . Additionally, lesions predictive of major adverse cardiac events demonstrate positive remodeling (PR) and low attenuation plaque (LAP) (8, 9) . Noncalcified plaques with #30 Hounsfield unit (HU) densities identified by CTA correlate closely with intravascular ultrasound (IVUS)-verified necrotic cores in coronary atherosclerotic plaques (2) . Although the presence of PR and LAP was associated with the development of acute coronary syndrome (ACS) during 2-year follow-up in our previous study (10) , the mid-term prognosis on the basis of CTA findings has not been reported. In the present study, we extended the follow-up period to investigate the relationship between CTA-verified high-risk plaque (HRP) and the incidence of ACS in mid-term follow-up. In patients with serial CTA, the association between plaque progression (PP) and ACS was also evaluated. The study endpoint was defined as ACS occurrence on the basis of the third universal definition of myocardial infarction (11) and the Canadian Cardiovascular Society grading of angina pectoris (12) .
METHODS
Briefly, ACS was defined as ischemic discomfort presenting with elevated troponin levels and ischemic discomfort that was Canadian Cardiovascular Society 
RESULTS
PATIENT-BASED ANALYSIS. In the 3,158 enrolled patients (age 66 AE 11 years, male 70%), the follow-up was a mean of 3.9 AE 2.4 years (range: 1 to 10.5 years;
IQR: 1.9 to 5.7 years). HRP was detected in 294 (9.3%) patients. The HRP(þ) patients differed significantly from HRP(À) patients: they were older; more likely male; more likely to have hypertension, dyslipidemia, diabetes mellitus, and a history of ACS; and more likely to be on statin therapy post-CTA ( Table 1) . >25 kg/m 2 , previous ACS, HRP, and SS were independent predictors of developing ACS ( Table 2) . (Online Figure 1B) . The numbers of patients with ACS each year on the basis of culprit lesion characteristics are shown in the Central Illustration. The cumulative number of patients with ACS at HRP lesions was higher in the first 5 years; however, the number of ACS at HRP(À) lesions became similar at 7 years.
SERIAL CTA ANALYSIS. Of the 449 patients who had serial CTA available for comparative analysis, the mean age was 65 AE 11 years, and 85% were male (Online Table 1 ). Median follow-up was 4.1 years, and the median interval period from CTA-1 to CTA-2 was 1
year. Twenty-six patients were excluded from serial CTA analysis because of intercurrent cardiac events before CTA-2: 8 ACS and 18 elective revascularization because of stable angina pectoris (SAP) ( Figure 4A ). Of 8 ACS, 7 had HRP on CTA-1 without SS, and 1 patient as did patients with SS than did those without (5.5% vs. 2.1%) (B). (C) Patients were classified into 5 groups on the basis of plaque characteristics and luminal stenosis [HRP(þ)/SS(þ); HRP(þ)/SS(À); HRP(À)/SS(þ); HRP(À)/SS(À); and no plaque]; event rates were 18.8%, 14.9%, 2.6%, 1.2%, and 0.6%, respectively. CTA ¼ computed tomography angiography; other abbreviations as in Figure 1 . Table 1 . Table 2 , Online Figure 2 ).
DISCUSSION
The presence of CTA-based HRP was an independent mid-term predictor of ACS, and all but 2 patients with The present study demonstrated that HRP continued to be an independent predictor of ACS in mid- current study (15) . In this IVUS study, plaques charac- Abbreviations as in Tables 1 and 2 . Prediction of ACS by CT Angiography
